Your browser doesn't support javascript.
loading
Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients.
Alshalalfa, Mohammed; Verhaegh, Gerald W; Gibb, Ewan A; Santiago-Jiménez, Maria; Erho, Nicholas; Jordan, Jennifer; Yousefi, Kasra; Lam, Lucia L C; Kolisnik, Tyler; Chelissery, Jijumon; Seiler, Roland; Ross, Ashley E; Karnes, R Jeffrey; Schaeffer, Edward M; Lotan, Tamara T; Den, Robert B; Freedland, Stephen J; Davicioni, Elai; Klein, Eric A; Schalken, Jack A.
Afiliação
  • Alshalalfa M; GenomeDx Biosciences Inc., Vancouver, BC, Canada.
  • Verhaegh GW; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Gibb EA; Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
  • Santiago-Jiménez M; GenomeDx Biosciences Inc., Vancouver, BC, Canada.
  • Erho N; GenomeDx Biosciences Inc., Vancouver, BC, Canada.
  • Jordan J; GenomeDx Biosciences Inc., Vancouver, BC, Canada.
  • Yousefi K; GenomeDx Biosciences Inc., Vancouver, BC, Canada.
  • Lam LLC; GenomeDx Biosciences Inc., Vancouver, BC, Canada.
  • Kolisnik T; GenomeDx Biosciences Inc., Vancouver, BC, Canada.
  • Chelissery J; GenomeDx Biosciences Inc., Vancouver, BC, Canada.
  • Seiler R; GenomeDx Biosciences Inc., Vancouver, BC, Canada.
  • Ross AE; GenomeDx Biosciences Inc., Vancouver, BC, Canada.
  • Karnes RJ; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Schaeffer EM; James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, MD, USA.
  • Lotan TT; Department of Urology, Mayo Clinic, Rochester, MN, USA.
  • Den RB; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Freedland SJ; Department of Pathology and Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Davicioni E; Sidney Kimmel Cancer Centre, Thomas Jefferson University, Philadelphia, PA, USA.
  • Klein EA; Department of Surgery, Division of Urology, Center of Integrated Research on Cancer and Lifestyle, Samuel Oschin Comprehensive Cancer Center, Cedars Sinai Medical Center, Los Angeles, CA, USA.
  • Schalken JA; GenomeDx Biosciences Inc., Vancouver, BC, Canada.
Oncotarget ; 8(31): 50804-50813, 2017 Aug 01.
Article em En | MEDLINE | ID: mdl-28881605
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article